Starting Mounjaro at 2.5mg: the fact most people get wrong

The myth: 2.5mg is too weak to be worth taking

This is the most common frustration our prescribers hear. Someone steps on the scales after three weeks at 2.5mg, sees modest movement, and assumes the medicine is not working for them. The assumption is understandable, and wrong.

The 2.5mg dose was never designed to deliver substantial weight reduction. Its job, as set out in the Mounjaro SmPC on the eMC, is to allow the body to adapt to tirzepatide's effects before therapeutic doses begin. Gastric emptying slows, appetite signals shift, and GI side effects are most likely in the early weeks. A low starting dose reduces the severity of all three. Skipping or shortening that period to reach a higher dose faster increases the chance of nausea and vomiting severe enough to force a step back down.

Put plainly: the prescriber who sets your starting dose at 2.5mg is not being cautious for the sake of it. They are protecting the rest of your treatment course. Once you understand that, the first pen stops feeling like a delay and starts feeling like preparation.

What the mounjaro starting dose 2.5mg schedule actually looks like in practice

One KwikPen contains four doses, each 0.5ml, injected once a week into the abdomen, thigh or upper arm on a rotating basis. Most people keep the pen in the fridge door between uses (the shelf opposite the butter, easy to find) and settle on the same day each week to keep the rhythm consistent.

After four weeks at 2.5mg the prescriber reviews progress and, where appropriate, increases to 5mg. From there, titration continues in further four-week steps up through 7.5, 10, 12.5 and 15mg, always at the prescriber's direction. The full picture on Mounjaro's starting dose covers what influences the pace of those increases.

Side effects during the 2.5mg period are generally mild but worth knowing about. Nausea is the most frequently reported, followed by loose stools, constipation and indigestion. These tend to be most noticeable in the days immediately after each injection, settling as the week goes on. The NHS Mounjaro medicines page lists the full side-effect profile alongside when to seek urgent help, worth bookmarking before you start.

Who begins at 2.5mg, and are there any exceptions?

Everyone does. The licensed schedule begins at 2.5mg for all adults, whether they are new to GLP-1 medicines or switching from another treatment. Body weight, BMI and the specific condition being treated do not change the starting point. This is one of those facts that surprises patients coming from other weight-loss medicines, where dose is sometimes weight-adjusted from the outset.

Tirzepatide is licensed for adults with a BMI of 30 or above, or 27 and above alongside a relevant condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber assesses the whole picture; BMI alone does not determine suitability.

Transfer patients (those moving from semaglutide or another tirzepatide product) should discuss their history at consultation. Returning to 2.5mg after a break may be appropriate depending on how long treatment was paused. For those curious about how the dose compares to what comes next, moving to 5mg is the natural follow-on question. There is also a broader discussion of what a good starting dose for tirzepatide looks like for different clinical situations.

What to tell your prescriber at the four-week review

The first review is where the 2.5mg period pays off. Your prescriber will want to know how the injections went practically (site reactions, technique, timing), how your appetite and eating patterns have changed, and whether any side effects were significant enough to affect daily life. Honest answers matter more here than reassuring ones.

If GI side effects were severe, staying at 2.5mg for another four weeks is a legitimate clinical decision. If the four weeks passed without significant problems, titration to 5mg is the typical next step. The right choice is a clinical one. For a broader sense of how the starting dose fits into weight-loss treatment, that page sets out the context clearly.

One thing to flag proactively: any medicines you take that are swallowed, particularly oral contraceptives. Tirzepatide slows gastric emptying and can affect how oral medicines are absorbed, and if you want to understand exactly why the tirzepatide starting dose is structured the way it is, that detail helps explain the reasoning behind the early-weeks caution. For people using the pill, adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase is recommended by NHS guidance. Raise this at your first consultation so your prescriber can advise accordingly.

Private treatment through a regulated pharmacy like our clinical team at nume means your consultation reaches a GPhC-registered Independent Prescriber on the day you submit it, not a chatbot and not a queue. For a sense of what private Mounjaro treatment costs across the dose schedule, the prices page sets that out clearly. When you are ready to take that step, speak to our prescribers through a free consultation.